ES456457A1 - Procedimiento para producir una composicion antimicrobial- mente activa. - Google Patents

Procedimiento para producir una composicion antimicrobial- mente activa.

Info

Publication number
ES456457A1
ES456457A1 ES456457A ES456457A ES456457A1 ES 456457 A1 ES456457 A1 ES 456457A1 ES 456457 A ES456457 A ES 456457A ES 456457 A ES456457 A ES 456457A ES 456457 A1 ES456457 A1 ES 456457A1
Authority
ES
Spain
Prior art keywords
skin
esp
migrate
natural
compsns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES456457A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaco Inc
Original Assignee
Pharmaco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaco Inc filed Critical Pharmaco Inc
Publication of ES456457A1 publication Critical patent/ES456457A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para producir una composición anti microbialmente activa, que no puede pasar a través de la piel, membranas mucosas o heridas de la piel ala circulación sistémica, caracterizado porque comprende hacer reaccionar a través de sustitución nucleófila, un principio antimicrobial farmacéuticamente activo elegido del grupo consistente en diaminas alifáticas, polimixinas, bacitracina, penicilinas, derivados de penicilina, cefalosporinas, aminofenoles, fenoles sustituidos, antibióticos poliénicos, productos mercuriales orgánicos, antibióticos de vancomicina, befenio, diclorofeno y hexilresorcinol, con un material soporte elegido del grupo consistente en polisacáridas naturales, polisacáridos modificados, polipéptidos naturales, polipéptidos sintéticos, vidrio , vidrio que tiene grupos funcionales activos unidos al mismo, y polímeros sintéticos, para formar un enlace covalente entre el principio farmacéuticamente activo y el material soporte, cuyo enlace es estable en todos los ambientes de utilización proyectados.
ES456457A 1976-03-02 1977-03-02 Procedimiento para producir una composicion antimicrobial- mente activa. Expired ES456457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66304676A 1976-03-02 1976-03-02

Publications (1)

Publication Number Publication Date
ES456457A1 true ES456457A1 (es) 1978-12-01

Family

ID=24660276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES456457A Expired ES456457A1 (es) 1976-03-02 1977-03-02 Procedimiento para producir una composicion antimicrobial- mente activa.

Country Status (10)

Country Link
JP (1) JPS52108016A (es)
AU (1) AU2271177A (es)
DE (1) DE2709059A1 (es)
DK (1) DK89277A (es)
ES (1) ES456457A1 (es)
FR (1) FR2342740A1 (es)
IT (1) IT1084022B (es)
NL (1) NL7702228A (es)
NO (1) NO770394L (es)
SE (1) SE7702261L (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
DE3230736A1 (de) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht An siliciumdioxid als traeger gebundene wirkstoffe, verfahren zu ihrer herstellung und ihre verwendung
US4496363A (en) * 1983-11-21 1985-01-29 Uop Inc. Antimicrobial fabrics
SE460017B (sv) * 1984-03-14 1989-09-04 Landstingens Inkopscentral Bakterieadsorberande komposition i vattenoloeslig form
US4708870A (en) * 1985-06-03 1987-11-24 E. I. Du Pont De Nemours And Company Method for imparting antimicrobial activity from acrylics
WO1990015628A1 (en) * 1989-06-14 1990-12-27 Cetus Corporation Polymer/antibiotic conjugate
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates
MY104520A (en) * 1989-11-15 1994-04-30 Novartis Ag Polymyxin conjugates.
CA2044663A1 (en) * 1990-07-12 1992-01-13 Makoto Tanaka Water-dispersible polyene antifungal complexes
US5292528A (en) * 1992-06-19 1994-03-08 Sunstar Kabushiki Kaisha Oral Composition
US6660267B1 (en) 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US5567685A (en) * 1994-08-16 1996-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Water-Soluble polyene conjugate
FR2751882B1 (fr) * 1996-07-31 1998-10-02 Inst Curie Surfaces hyperbactericides
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
US7459167B1 (en) 2000-07-27 2008-12-02 3M Innovative Properties Company Biocidal polyurethane compositions and methods of use
US7919480B2 (en) 2007-05-03 2011-04-05 Ethicon, Inc. Polymers having covalently bound antibiotic agents

Also Published As

Publication number Publication date
SE7702261L (sv) 1977-09-07
AU2271177A (en) 1978-08-31
JPS52108016A (en) 1977-09-10
DK89277A (da) 1977-09-03
FR2342740A1 (fr) 1977-09-30
NO770394L (no) 1977-09-05
DE2709059A1 (de) 1977-09-15
IT1084022B (it) 1985-05-25
NL7702228A (nl) 1977-09-06

Similar Documents

Publication Publication Date Title
ES456457A1 (es) Procedimiento para producir una composicion antimicrobial- mente activa.
FI973419A (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
BG60261B1 (bg) Лекарствена форма на цефаклор с продължително действие
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
ATE179887T1 (de) Arzneimittelzubereitung
US4904469A (en) Therapeutic agents for enzymatic wound cleaning
PT83007B (pt) Processo para a preparacao de proantocianidina a2 , e de composicoes farmaceuticas que a contem
AU469963B2 (en) Treatment of cellulosic matter with activated nitrogen or other activated gases
SE7608812L (sv) Antiseptiska kompositioner
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
DE59102701D1 (de) Arzneimittelzubereitung zur systemischen Behandlung von Zier- und Nutzfischen.
DK0855916T3 (da) Farmaceutisk præparat indeholdende en Activin-stimulator
NO1996005I1 (no) Doxycyclin-carrageenat
ATE108488T1 (de) Biotestverfahren für chemikalien, welche prooxidante zustände generieren.
JPS5329908A (en) Immobilized haptoglobin preparation
NO179436C (no) Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk
FI99114B (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
ES2084747T3 (es) Polimeros en emulsion liberados de emulsionantes en preparados farmaceuticos con liberacion retardada de la sustancia activa, y su preparacion.
RU93031184A (ru) Препарат для профилактики и лечения заболеваний птиц
IT8448710A1 (it) Riduzione degli effetti tossici causati da farmaci antrachinonici
SE8604587D0 (sv) Lekemedelssats for sarlekningsstimulering samt sett att anvenda och tillverka satsen
Aonuma et al. Studies on biologically active substances formed by Bacilli. V. Removal of surface active factor and lipids from the serum calcium decreasing substance alpha-factor produced by B. subtilis K (author's transl)
ATE339979T1 (de) Abgabesystem für blutprodukte
AU4329489A (en) Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer
TH3619EX (th) สารเชิงซ้อนของอิมมิวโนเจนกับสารพากรรมวิธีการผลิต และการใช้สารดังกล่าว